Form 4 for EW Edwards Lifesciences
Accepted 2024-03-07 00:00:00 ET · period of report 2024-03-07 · accession 0001225208-24-003866 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-07 | 2024-03-07 | EW | Lippis Daniel J. | CVP, JAPAC | M - OptEx | $36.75 | +1,715 | 18.9K | +10% | +$63.0K |
| D | 2024-03-07 | 2024-03-07 | EW | Lippis Daniel J. | CVP, JAPAC | S - Sale+OE | $90.98 | -1,715 | 17.2K | -9% | -$156.0K |
| D | 2024-03-07 | 2024-03-07 | EW | Lippis Daniel J. | CVP, JAPAC | M - OptEx | $0.00 | -1,715 | 1,714 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-07 | M | A | 1,715 | $36.75 | 18,928.21 | D | — | — | |
| 2 | Common | Common Stock | 2024-03-07 | S | D | 1,715 | $90.98 | 17,213.21 | D | — | — | |
| 3 | Derivative | Employee Stock Option (Right to Acquire) | 2024-03-07 | M | D | 1,715 | $0.00 | 1,714 | D | $36.75 · 2018-05-11 to 2024-05-10 | 1,715 Common Stock |